Published in AIDS Weekly, June 7th, 2004
The announcement came as three major U.S. pharmaceutical companies said they'll work to develop an AIDS drug offering a single daily dose.
In a joint statement, Bristol-Myers Squibb Co., Gilead Sciences Inc. and Merck & Co. Inc., said they will pursue research to combine three of their HIV medicines into a single tablet.
In Geneva, U.S. Health and Human Services Secretary Tommy Thompson said the Food and Drug Administration...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.